Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients

Bone Marrow Transplantation, Published online: 10 October 2023; doi:10.1038/s41409-023-02119-9Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients

Source: Bone Marrow Transplantation - October 10, 2023 Category: Hematology Authors: Christopher Strouse Sarah L. Mott Brian J. Smith Margarida Magalhaes-Silverman Umar Farooq Fenghuang Zhan Yogesh Jethava Guido Tricot Source Type: research